Literature DB >> 8254740

Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape.

H Hengel1, P Lucin, S Jonjić, T Ruppert, U H Koszinowski.   

Abstract

An immediate-early protein of murine cytomegalovirus (MCMV), pp89, elicits an immunodominant and protective major histocompatibility complex (MHC) class I Ld-restricted CD8+ T-lymphocyte response. Remarkably, presentation of the naturally processed peptide of pp89, the nonapeptide YPHFMPTNL, is abolished during permissive MCMV infection in vitro. This defect in pp89 presentation is due to the expression of MCMV early gene functions that specifically block the transport of peptide-charged MHC class I complexes to the cell surface (M. Del Val, H. Hengel, H. Häcker, U. Hartlaub, T. Ruppert, P. Lucin, and U. H. Koszinowski, J. Exp. Med. 176:729-738, 1992). Here, we demonstrate that MCMV-specific CD8+ T lymphocytes can reconstitute pp89 presentation in a parakrine fashion. The lymphocytes mediate the restoration of antigen presentation by MCMV-infected cells by releasing gamma interferon (IFN-gamma). IFN-gamma has no effect on synthesis and stability of the viral antigen pp89 nor does it interfere with the expression of viral early genes and their inhibitory effect on MHC class I molecular maturation. IFN-gamma results in a 25-fold increase in the synthesis of MHC class I molecules and a similar increase in the abundance of pp89-derived peptide. Many of the MHC molecules remain retained by the viral effect, but a surplus of MHC molecules escapes the effect and provides the effective surface presentation of the peptide. Adoptive cell transfer studies demonstrate the IFN-gamma dependence of CD8+ T-lymphocyte function in vivo. Altogether, these data reconcile the paradoxical findings of an impaired pp89 presentation in vitro in parallel with pp89-specific CD8+ T-cell protection in vivo. The results also imply a role of IFN-gamma in the T-lymphocyte-mediated control of cytomegalovirus infection. The known propensity of cytomegalovirus to cause serious disease in the immunocompromised host is discussed in the light of these findings.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8254740      PMCID: PMC236288     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  A nucleoprotein peptide of influenza A virus stimulates assembly of HLA-B27 class I heavy chains and beta 2-microglobulin translated in vitro.

Authors:  S Kvist; U Hamann
Journal:  Nature       Date:  1990-11-29       Impact factor: 49.962

2.  Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.

Authors:  O Rötzschke; K Falk; K Deres; H Schild; M Norda; J Metzger; G Jung; H G Rammensee
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

3.  ATP is required for in vitro assembly of MHC class I antigens but not for transfer of peptides across the ER membrane.

Authors:  F Lévy; R Gabathuler; R Larsson; S Kvist
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

4.  Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis.

Authors:  B Echtenacher; W Falk; D N Männel; P H Krammer
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

5.  A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway.

Authors:  T Spies; M Bresnahan; S Bahram; D Arnold; G Blanck; E Mellins; D Pious; R DeMars
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

6.  A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin.

Authors:  H Browne; G Smith; S Beck; T Minson
Journal:  Nature       Date:  1990-10-25       Impact factor: 49.962

7.  Second proteasome-related gene in the human MHC class II region.

Authors:  A Kelly; S H Powis; R Glynne; E Radley; S Beck; J Trowsdale
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

8.  A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.

Authors:  C Sibille; K Gould; G Hämmerling; A Townsend
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

9.  The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structure.

Authors:  W R Lie; N B Myers; J M Connolly; J Gorka; D R Lee; T H Hansen
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

10.  Disparate interaction of peptide ligand with nascent versus mature class I major histocompatibility complex molecules: comparisons of peptide binding to alternative forms of Ld in cell lysates and the cell surface.

Authors:  J D Smith; W R Lie; J Gorka; C S Kindle; N B Myers; T H Hansen
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  48 in total

1.  Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus.

Authors:  H Hengel; U Reusch; G Geginat; R Holtappels; T Ruppert; E Hellebrand; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance.

Authors:  C Benz; H Hengel
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

3.  Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis.

Authors:  Moon Jung Song; Seungmin Hwang; Wendy H Wong; Ting-Ting Wu; Sangmi Lee; Hsiang-I Liao; Ren Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

Review 4.  CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.

Authors:  Rafaela Holtappels; Verena Böhm; Jürgen Podlech; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2008-03-15       Impact factor: 3.402

5.  Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates.

Authors:  R Holtappels; J Podlech; G Geginat; H P Steffens; D Thomas; M J Reddehase
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.

Authors:  P J Lehner; J T Karttunen; G W Wilkinson; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

7.  A short cis-acting motif in the M112-113 promoter region is essential for IE3 to activate M112-113 gene expression and is important for murine cytomegalovirus replication.

Authors:  Kareni J Perez; Francisco Puerta Martínez; Ruth Cosme-Cruz; Neysa M Perez-Crespo; Qiyi Tang
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

8.  Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.

Authors:  Niels A W Lemmermann; Kerstin Gergely; Verena Böhm; Petra Deegen; Torsten Däubner; Matthias J Reddehase
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

9.  Reduced expression of gamma interferon in serum and marked lymphoid depletion induced by Porphyromonas gingivalis increase murine morbidity and mortality due to cytomegalovirus infection.

Authors:  Jacob Stern; Ela Shai; Batia Zaks; Amal Halabi; Yael Houri-Haddad; Lior Shapira; Aaron Palmon
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

10.  Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro.

Authors:  J L Davignon; P Castanié; J A Yorke; N Gautier; D Clément; C Davrinche
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.